News & Announcements

IPO of Orion Pharma Ltd.

We are pleased to announce that the IPO (Initial Primary Offerings) subscription of Orion Pharma Limited will be held according to following schedule: For Resident Bangladeshis: Subscription Open

Annual General Meeting (AGM)

Notice is hereby given that the Annual General Meeting (AGM) of Shareholders of Orion Pharma Limited (Previously Orion Laboratories Limited) shall be held in its New Factory Premises at Hobirbari, Va

New Product Launch: Fostat-40

Orion Pharma Ltd. has launched Fostat 40 mg tablet a brand of Febuxostat INN. Febuxostat is a USFDA approved drugs for Chronic Gout & has the documented superiority over conventional treatment options

FIRST PAGE | PREV 5 PAGE40